Bangladesh vs Mus: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Bangladesh
100.0%
in 2014
Mus
100.0%
in 2014
Bangladesh rank
1st
Mus rank
1st
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Bangladesh
- Mus
How they compare
Bangladesh currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
The two have swapped places 1 time across 7 shared years of data; in 2008 it was Bangladesh ahead.
Bangladesh ranks 1st and Mus ranks 1st of 104 countries.
Across the 2 decades both report, Bangladesh averaged higher in 1 and Mus in 1.
Head to head by decade
| Decade | Bangladesh | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 78.5% | 75.0% | 3.5% | Bangladesh |
| 2010s | 98.0% | 100.0% | 2.0% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Bangladesh or Mus?
- Bangladesh, at 100.0% against 100.0% in Mus as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Bangladesh and Mus?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Mus?
- 7 years are reported by both, from 2008 to 2014.
- How do Bangladesh and Mus rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Bangladesh ranks 1st and Mus ranks 1st of 104 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.